Literature DB >> 27576521

Use of Baicalin-Conjugated Gold Nanoparticles for Apoptotic Induction of Breast Cancer Cells.

Donghyun Lee1, Wan-Kyu Ko1, Deok-Sang Hwang2, Dong Nyoung Heo3, Sang Jin Lee1, Min Heo1, Kook-Sun Lee4, Ji-Yoon Ahn2, Junyoung Jo5, Il Keun Kwon6.   

Abstract

Baicalin (BC) has been used for cancer therapy due to its multiple effects as an anti-cancer drug. However, the effective delivery of this molecule to targeted cells is difficult. Gold nanoparticles (AuNPs) conjugated with thiolated beta cyclodextrin (AuNP-S-β-CD) were used as a delivery vector in this study. Cell viability tests were evaluated by cell counting kit-8 (CCK) and live/dead cell assay. To demonstrate the proliferation inhibition effect on Michigan Cancer Foundation-7 (MCF-7) cells by BC, we analyzed using Hoechst 33342 staining assay and gel electrophoresis. The S-β-CD conjugated AuNPs were characterized by transmission electron microscopy (TEM), 1H nuclear magnetic resonance ((1)H NMR), and ultraviolet visible (UV-vis) spectroscopy. AuNP-S-β-CD with approximately 40 μM of BC loaded by inclusion complex showed an inhibition effect on MCF-7 cells by inducing apoptosis. Apoptosis test results were evaluated by analyzing the expression of typical apoptic markers such as cleaved caspase-3, full length caspase-3, and apaf-1 in western blot assay. These results demonstrated that AuNP-S-β-CD-BC inhibited the proliferation of cancerous MCF-7 cells by inducing apoptosis. These findings suggested that AuNP-S-β-CD-BC could be a promising agent for chemotherapeutic usage.

Entities:  

Keywords:  Anti-cancer; Apoptosis; Baicalin; Beta cyclodextrin; Gold nanoparticle

Year:  2016        PMID: 27576521      PMCID: PMC5005216          DOI: 10.1186/s11671-016-1586-3

Source DB:  PubMed          Journal:  Nanoscale Res Lett        ISSN: 1556-276X            Impact factor:   4.703


Background

Breast cancer is one of the most common forms of cancer in women in the world. The rate of breast cancer incidence is increasing rapidly because of changes in diet, breastfeeding methods, and the environment. Many kinds of therapy have been tried for treatment of breast cancer [1]. The most successful treatments have been chemotherapy and radiotherapy. However, these therapies are often accompanied by side-effects [2, 3]. In order to alleviate these adverse side-effects, studies are actively underway to develop naturally based treatments for breast cancer [4-7]. Scutellaria baicalensis Georgi (SB), a common medicinal herb, contains various flavonoids such as baicalin (BC), baicalein, wogonin, wogonoside, oroxylin A, and oroxylin A-7. These are well-known constituents which contribute to SB biological activity [8]. Especially, BC and baicalein have been reported for inhibition of cancer proliferation as well as inducing apoptosis of cancer cells [9-12]. BC has useful properties for use as a drug; however, it is difficult to deliver BC in a targeted fashion towards cancer cells. Recently, in the biomaterials research field, gold nanoparticles (AuNPs) bearing moieties which target receptors on the cell surface have been used for delivery of materials into cells through endocytosis [13-16]. In addition, immune cells containing AuNPs were used to utilize in cancer therapy field [17-20]. According to Albanese and Chan, AuNPs have no cytotoxicity and have a great capacity for cellular uptake [21]. Furthermore, biological drugs such as proteins, DNA, and RNA have been investigated as materials that can be delivered via various sizes of AuNPs or gold nanorods [22-29]. In this study, we designed a functionalized AuNPs modified using thiolated beta-cyclodextrin (AuNP-S-β-CD) as a means to load BC. Cell counting and western blot assays were conducted to prove the anti-cancer effectiveness of AuNP-S-β-CD-BC. Michigan Cancer Foundation-7 (MCF-7) cells, which are typical breast cancer cells, were used in all the cellular tests.

Methods

Gold (III) chloride hydrate (99.999 % trace metals basis), sodium citrate, iodine, beta cyclodextrin, sodium methoxide, baicalin, and Hoechst 33342 stain were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s modified eagle medium (DMEM), fetal bovine serum (FBS), penicillin streptomycin (Pen strep), and Dulbecco’s phosphate-buffered saline (DPBS) were purchased from GIBCO BRL (Invitrogen Co., USA). Antibody for β-actin was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies for cleaved caspase-3, full-length caspase-3, and apaf-1 were purchased from Cell Signaling Technology (Beverly, MA, USA). MCF-7 cells were purchased from Invitrogen (Carlsbad, CA, USA) and cultured in a tissue culture plate filled with DMEM (containing 1 % PS and 10 % FBS) in a 37 °C heated-humidified atmosphere with 5 % CO2. MCF-7 cells were seeded into 24-well plates (1 × 105 cells/well) and incubated for 24 and 48 h, respectively. At each predetermined timepoint, the optical densities of the cells were evaluated by using a cell counting kit-8 (CCK, Dojindo, Kumamoto, Japan). In order to quantify, we measured the cell viability percentage amongst all groups. The intensity was measured by a microplate reader (BioRad, USA) at a wavelength of 450 nm. The live/dead cell assay kit, including calcein-AM/ethidium homodimer-1 (EthD-1) was used to demonstrate the inhibition effect of BC qualitatively. MCF-7 cells were seeded at a density of 2 × 105 cells/well in a medium containing 100 μM of BC for Hoechst 33342 and DNA fragmentation assay. After 2 days, the cells were stained with Hoechst 33342 solution for 1 h in a 37 °C heated-humidified atmosphere with 5 % CO2, and were then observed by a fluorescent microscope (Olympus IX71, Japan). For DNA fragmentation assay, the cells were lysed by using a lysis buffer containing a protease inhibitor. A total of 250 μg of gDNA was extracted from each group using a gDNA purification kit (Taiwan). The gDNA was tested using gel electrophoresis in a 2 % agarose gel and measured by ChemiDoc XRS System (Bio-Rad, Hercules, CA, USA). AuNPs were produced by reducing gold chloride hydrate as previously described [30]. Briefly, 0.02 % gold chloride hydrate solution (800 ml) was boiled to 100 °C under a reflux condenser, and 2 % sodium citrate solution (15 ml) was added into the gold chloride hydrate solution. The mixed solution reaction changed color to dark purple. The temperature was held for 15 min and then allowed to cool gradually to room temperature. S-β-CD was prepared as described in our previous study [31]; 50 μM of BC and 50 μM of AuNP-S-β-CD were mixed and ultra-sonicated for 5 min to load the BC into the β-CD. The loading volume of BC on AuNP-S-β-CD was calculated by comparing the optical density of the BC solution group with the AuNP-S-β-CD-BC solution group. The synthesized/conjugated materials were analyzed by transmission electron microscopy (TEM) (H-7100, Hitachi, Japan), 1H nuclear magnetic resonance spectrometer (1H NMR spectrometer, INOVA400, CA, USA), and ultraviolet visible (UV-vis) spectroscopy (1650PC spectrophotometer, Shimadzu, Japan). MCF-7 cells were seeded at a density of 1 × 105 cells/well with a medium-containing AuNP-S-β-CD and AuNP-S-β-CD-BC in 6-well plates and incubated for 24 and 48 h, respectively. At the predetermined hour, MCF-7 cells were lysed by the addition of cold RIPA lysis buffer containing 0.5 M Tris-HCl, pH 7.4, 1.5 M NaCl, 2.5 % deoxycholic acid, 10 % NP-40, and 10 mM EDTA along with protease and phosphatase inhibitors. The cell lysates were incubated in an ice box for 30 min and then centrifuged at 1.3 × 104 rpm for 10 min. Aliquots of 40 μg of equal amounts of protein was added into sodium dodecyl sulfate and loaded into polyacrylamide gel for electrophoreses (SDS-PAGE). These were subsequently transferred using a nitrocellulose transfer membrane. After blocking the nitrocellulose transfer membrane with 5 % skim milk, the membrane was probed with cleaved caspase-3, full-length caspase-3, apaf-1, and β-actin followed by incubation with an appropriate secondary antibody conjugated to horseradish peroxidase. Signals were detected using a ChemiDoc XRS System (Bio-Rad), and β-actin was regarded as an internal control group. Statistical analysis was performed using Student’s t test. All values were expressed as means ± standard deviations, and all the experimental groups compared with the control group.

Results and Discussion

We performed a cell viability test in order to confirm the anti-cancer effectiveness of BC. The proliferation inhibitory rate was evaluated using a microplate leader. Cells were treated with various concentrations of BC (1, 10, 50, 100, and 200 μM) and were measured at 24 and 48 h, respectively. After 24 h, the results of the cell viability test demonstrated cell viability at 101, 91, 79, 64, and 46 % for doses of 1, 10, 50, 100, and 200 μM BC, respectively (Fig. 1a). After 48 h of incubation, the viability of each group was further reduced as compared with the 24-h groups. The live/dead cell assay also showed that BC inhibited MCF-7 proliferation in a dose-dependent manner. Especially, almost all MCF-7 cells were dead when exposed to doses greater than 100 μM of BC (Fig. 1b).
Fig. 1

Evaluation of cell viability in MCF-7 cells using cell counting kit (a) and live and dead cell assay (b). Single asterisk indicates significant difference of p < 0.05, double asterisks indicate significant difference of p < 0.001 (N = 3)

Evaluation of cell viability in MCF-7 cells using cell counting kit (a) and live and dead cell assay (b). Single asterisk indicates significant difference of p < 0.05, double asterisks indicate significant difference of p < 0.001 (N = 3) Hoechst 33342 staining and DNA fragmentation assay were carried out to analyze the BC-induced apoptosis effect (Fig. 2). In the fluorescence microscopic image, 100-μM BC-treated cells showed significantly higher nuclear fragmentation which confirms apoptosis (Fig. 2b). Figure 2c shows the “ladder-shape” DNA fragmentation which also indicates DNA apoptosis [32]. These results show that apoptosis occurred in the BC-treated group.
Fig. 2

Fluorescent images of MCF-7 cells (a, b) under apoptosis. DNA fragmentation induced by BC as determined by gel electrophoresis (c)

Fluorescent images of MCF-7 cells (a, b) under apoptosis. DNA fragmentation induced by BC as determined by gel electrophoresis (c) We designed an AuNP-S-β-CD which can be a delivery vector for BC by serving as an inclusion complex. The conjugated complexes were fully characterized by TEM, 1H NMR, and UV-vis spectroscopy. In this study, we manufactured 30-nm-diameter AuNPs which have no inherent toxicity towards the body [33]. The AuNPs were conjugated with S-β-CD in order to provide for inclusion of BC. Figure 3a shows that the AuNPs had a spherical shape. The OH terminal groups of β-CD were substituted with a thiol group in order to allow for conjugation to the AuNPs. The substituted β-CD demonstrated SH peak in the 1H NMR graph (Fig. 3b). The thiol group of the β-CD enables bonding of β-CD with AuNP [34]. We confirmed S-β-CD conjugation to AuNPs by using UV-vis spectroscopy (Fig. 3c). The maximum absorbance of the control AuNPs group was found to occur at 525 nm. For the AuNP-S-β-CD group, the maximum absorbance shifted to the right (533 nm) as compared with the AuNPs group. This shift in the maximum absorbance wavelength indicates successful attachment of the S-β-CD on AuNPs [35]. We sonicated BC with AuNP-S-β-CD in order to generate the AuNP-S-β-CD-BC complex and confirmed that approximatively 40 μM BC was loaded onto the AuNP-S-β-CD (Fig. 3d).
Fig. 3

TEM image of gold nanoparticles (a), 1H NMR graph of S-β-CD (b), absorbances of AuNP and AuNP-S-β-CD (c), absorbance spectra of BC and AuNP-SH-β-CD-BC (d) as measured by UV-vis spectroscopy

TEM image of gold nanoparticles (a), 1H NMR graph of S-β-CD (b), absorbances of AuNP and AuNP-S-β-CD (c), absorbance spectra of BC and AuNP-SH-β-CD-BC (d) as measured by UV-vis spectroscopy The AuNP-S-β-CD-BC group also demonstrated inhibitory effects against MCF-7 cells after 48 h of incubation (Fig. 4a). The proliferation of MCF-7 cells was significantly inhibited by the loaded BC released from the AuNP-S-β-CD. When apoptosis occurs in cancer cells, the apaf-1 signal is expressed. Subsequently, the full-length caspase-3 signal decreases and the cleaved caspase-3 signal increases [36]. The western blot assay results demonstrate that apoptosis occurs in AuNP-S-β-CD-BC group cells (Fig. 4b). Apaf-1 and cleaved caspase-3 bands from the AuNP-S-β-CD-BC groups were observed to have a higher intensity as compared with AuNP-S-β-CD alone and control group. These results demonstrate that the BC complexed onto AuNP-S-β-CD-induced apoptosis of MCF-7 cells.
Fig. 4

Anti-proliferation effects of AuNP-S-β-CD-BC against MCF-7 cells (a) the expression of cleaved caspase-3, full cleaved caspase-3, and Apaf-1 signals as measured from samples treated with AuNP-S-β-CD and AuNP-S-β-CD-BC (b). Single asterisk indicates significant difference of p < 0.05, double asterisks indicate significant difference of p < 0.001 (N = 3)

Anti-proliferation effects of AuNP-S-β-CD-BC against MCF-7 cells (a) the expression of cleaved caspase-3, full cleaved caspase-3, and Apaf-1 signals as measured from samples treated with AuNP-S-β-CD and AuNP-S-β-CD-BC (b). Single asterisk indicates significant difference of p < 0.05, double asterisks indicate significant difference of p < 0.001 (N = 3)

Conclusions

We prepared AuNP-S-β-CD-BC complex for delivery of BC as a chemotherapeutic strategy. Spherical AuNPs, 30 nm in diameter, were successfully conjugated with S-β-CD. Subsequently, BC was complexed onto these AuNP-S-β-CD. The anti-proliferation effectiveness of the AuNP-S-β-CD system complexed with BC was confirmed using MCF-7 cells. All the results indicated that BC from this system could induce apoptosis of MCF-7 cells. Although future studies will be necessary to confirm anti-cancer effects on the in vivo animal studies, these findings and previous studies reporting the functionalized gold nanoparticle for drug delivery system suggest that the baicalin loaded AuNPs are effective materials for anti-cancer treatment.
  29 in total

Review 1.  Side effects of adjuvant treatment of breast cancer.

Authors:  C L Shapiro; A Recht
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

Review 2.  Preparation of Gold Nanorods and Their Applications in Photothermal Therapy.

Authors:  Kai Xia; Liming Zhang; Yuanfu Huang; Zhuoxuan Lu
Journal:  J Nanosci Nanotechnol       Date:  2015-01

Review 3.  Preparation and biomedical applications of gold-coated magnetic nanocomposites.

Authors:  Hongrong Jiang; Xin Zeng; Nongyue He; Yan Deng; Guangming Lu; Kai Li
Journal:  J Nanosci Nanotechnol       Date:  2013-03

Review 4.  Targeting apoptosis pathways in cancer therapy.

Authors:  Irene M Ghobrial; Thomas E Witzig; Alex A Adjei
Journal:  CA Cancer J Clin       Date:  2005 May-Jun       Impact factor: 508.702

Review 5.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

6.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

7.  Size-Dependent Endocytosis of Nanoparticles.

Authors:  Sulin Zhang; Ju Li; George Lykotrafitis; Gang Bao; Subra Suresh
Journal:  Adv Mater       Date:  2009       Impact factor: 30.849

8.  High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitro.

Authors:  Adam Yuh Lin; Jessica Lunsford; Adham Sean Bear; Joseph Keith Young; Phillip Eckels; Laureen Luo; Aaron Edward Foster; Rebekah Anna Drezek
Journal:  Nanoscale Res Lett       Date:  2013-02-12       Impact factor: 4.703

9.  A facile method for the detection of DNA by using gold nanoparticle probes coupled with dynamic light scattering.

Authors:  Yang Zhang; Wei-Wei Fei; Neng-Qin Jia
Journal:  Nanoscale Res Lett       Date:  2012-10-10       Impact factor: 4.703

10.  Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype.

Authors:  Takayo Fukuda; Rie Horii; Naoya Gomi; Yumi Miyagi; Shunji Takahashi; Yoshinori Ito; Futoshi Akiyama; Shinji Ohno; Takuji Iwase
Journal:  Springerplus       Date:  2016-02-24
View more
  8 in total

1.  Counting Chromosomes in Individual Bacteria to Quantify Their Impacts on Persistence.

Authors:  Allison M Murawski; Katherine Rittenbach; Christina J DeCoste; Gary Laevsky; Mark P Brynildsen
Journal:  Methods Mol Biol       Date:  2021

2.  A Combination of Baicalin and Berberine Hydrochloride Ameliorates Dextran Sulfate Sodium-Induced Colitis by Modulating Colon Gut Microbiota.

Authors:  Yonggang Yan; Luhan Li; Kenan Wu; Gang Zhang; Liang Peng; Yanni Liang; Zheng Wang
Journal:  J Med Food       Date:  2022-08       Impact factor: 2.542

3.  Baicalin Suppresses Hypoxia-Reoxygenation-Induced Arterial Endothelial Cell Apoptosis via Suppressing PKCδ/p53 Signaling.

Authors:  Xiaoling Shou; Bozhong Wang; Rongfang Zhou; Lei Wang; Aihua Ren; Shangping Xin; Liyue Zhu
Journal:  Med Sci Monit       Date:  2017-12-22

4.  Polymeric nanocapsular baicalin: Chemometric optimization, physicochemical characterization and mechanistic anticancer approaches on breast cancer cell lines.

Authors:  Riham I El-Gogary; Sara A Abdel Gaber; Maha Nasr
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

Review 5.  Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review.

Authors:  Xiao-Yang Chen; Lin-Yue Lanry Yung; Puay Hoon Tan; Boon Huat Bay
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

6.  Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway.

Authors:  Leyi Ma; Fan Wu; Qingqing Shao; Guang Chen; Lijun Xu; Fuer Lu
Journal:  Drug Des Devel Ther       Date:  2021-07-21       Impact factor: 4.162

Review 7.  Secondary Metabolites in the Green Synthesis of Metallic Nanoparticles.

Authors:  Gregory Marslin; Karthik Siram; Qaisar Maqbool; Rajendran Kamalabai Selvakesavan; Dariusz Kruszka; Piotr Kachlicki; Gregory Franklin
Journal:  Materials (Basel)       Date:  2018-06-03       Impact factor: 3.623

8.  Baicalin Inhibits Cell Viability, Migration and Invasion in Breast Cancer by Regulating miR-338-3p and MORC4.

Authors:  Xin Duan; Guangcheng Guo; Xinhong Pei; Xinxing Wang; Lin Li; Youyi Xiong; Xinguang Qiu
Journal:  Onco Targets Ther       Date:  2019-12-17       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.